Hepatocellular redistribution of multidrug resistant protein (MRP2): A compensatory mechanism in antidepressant induced cholestasis

被引：0
|
作者：
Milkiewicz, P
Chilton, A
Hubscher, SG
Elias, E
机构：
[1] Univ Birmingham, Dept Pathol, Birmingham, W Midlands, England
[2] Pomeranian Med Sch, Dept Gastroenterol, Szczecin, Poland
[3] Queen Elizabeth Hosp, Liver & Hepatobiliary Unit, Birmingham B15 2TH, W Midlands, England
来源：
GUT | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
388
引用
收藏
页码：A105 / A105
页数：1
相关论文
共 50 条
  • [21] Functional analysis of mouse and monkey multidrug resistance-associated protein 2 (Mrp2)
    Ninomiya, Mizuki
    Ito, Kousei
    Hiramatsu, Remi
    Horie, Toshiharu
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (12) : 2056 - 2063
  • [22] Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis
    Kullak-Ublick, GA
    Baretton, GB
    Oswald, M
    Renner, EL
    Paumgartner, G
    Beuers, U
    HEPATOLOGY RESEARCH, 2002, 23 (01) : 78 - 82
  • [23] Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export
    Evers, R
    de Haas, M
    Sparidans, R
    Beijnen, J
    Wielinga, PR
    Lankelma, J
    Borst, P
    BRITISH JOURNAL OF CANCER, 2000, 83 (03) : 375 - 383
  • [24] Induction of intestinal multidrug resistance-associated protein 2 (Mrp2) by spironolactone in rats
    Ruiz, Maria L.
    Villanueva, Silvina S. M.
    Luquita, Marcelo G.
    Pellegrino, Jose M.
    Rigalli, Juan P.
    Arias, Agostina
    Sanchez Pozzi, Enrique J.
    Mottino, Aldo D.
    Catania, Viviana A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 623 (1-3) : 103 - 106
  • [25] Regulation of multidrug resistance-associated protein 2 (MRP2) by dehydroepiandrosterone and its conjugates
    Han, Yong-Hae
    Chen, Cliff
    Wang, Bonnie
    Yang, Zheng
    Marathe, Punit
    Rodrigues, David
    DRUG METABOLISM REVIEWS, 2006, 38 : 226 - 226
  • [26] Effects of tauroursodeoxycholic acid on protein kinase C isoforms and on canalicular Mrp2 in experimental cholestasis
    Beuers, U
    Bilzer, M
    Chittattu, A
    Kullak-Ublick, GA
    Keppler, D
    Paumgartner, G
    Dombrowski, F
    BIOLOGY OF BILE ACIDS IN HEALTH AND DISEASE, 2001, 120 : 245 - 248
  • [27] Mrp2 is essential for estradiol-17β(β-D-glucuronide)-induced cholestasis in rats
    Huang, LY
    Smit, JW
    Meijer, DKF
    Vore, M
    HEPATOLOGY, 2000, 32 (01) : 66 - 72
  • [28] Multidrug resistance protein 2 (ABCC2/MRP2) is an important determinant of paclitaxel pharmacokinetics
    Lagas, Jurjen S.
    Vlaming, Maria L.
    Wagenaar, Els
    Schinkel, Alfred H.
    van Tellingen, Olaf
    Jansen, Robert S.
    Rosing, Hilde
    Beijnen, Jos H.
    DRUG METABOLISM REVIEWS, 2006, 38 : 248 - 249
  • [29] COX2 and multidrug resistance protein 2 (MRP2) in medullary thyroid carcinomas (MTC).
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 419 - 419
  • [30] Tauroursodeoxycholate (TUDCA)protects against redistribution of multidrug resistant protein 2 (Mrp2) and disruption of F-actin caused by taurolithocholate (TLC); A study in isolated rat hepatocyte couplets.
    Milkiewicz, P
    Roma, MG
    Mills, CO
    Coleman, R
    Elias, E
    HEPATOLOGY, 1999, 30 (04) : 461A - 461A
12345